应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02607 上海医药
交易中 05-12 10:35:13
12.240
+0.090
+0.74%
最高
12.290
最低
12.010
成交量
105.77万
今开
12.010
昨收
12.150
日振幅
2.30%
总市值
453.86亿
流通市值
112.49亿
总股本
37.08亿
成交额
1,293万
换手率
0.12%
流通股本
9.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
每周股票复盘：上海医药（601607）利伐沙班片获泰国注册证书
证券之星 · 05-10 02:29
每周股票复盘：上海医药（601607）利伐沙班片获泰国注册证书
上海医药（601607）披露持股5%以上股东权益变动触及1%刻度的提示性公告，5月8日股价下跌0.35%
证券之星 · 05-08
上海医药（601607）披露持股5%以上股东权益变动触及1%刻度的提示性公告，5月8日股价下跌0.35%
东南亚市场再下一城：上海医药附属公司利伐沙班片在泰国获批上市
财中社 · 05-07
东南亚市场再下一城：上海医药附属公司利伐沙班片在泰国获批上市
大摩：上海医药(02607)首季业绩符预期 予上海医药(601607.SH)A股“与大市同步”评级
智通财经 · 05-06
大摩：上海医药(02607)首季业绩符预期 予上海医药(601607.SH)A股“与大市同步”评级
格隆汇沽空预警榜 | 5月4日
格隆汇 · 05-06
格隆汇沽空预警榜 | 5月4日
每周股票复盘：上海医药（601607）一季度营收752.62亿元
证券之星 · 05-02
每周股票复盘：上海医药（601607）一季度营收752.62亿元
上海医药（601607）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 05-01
上海医药（601607）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元
公告速递 · 04-29
上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元
上海医药(02607)一季度归母净利润14.18亿元 同比增长6.35%
智通财经 · 04-29
上海医药(02607)一季度归母净利润14.18亿元 同比增长6.35%
上海医药清仓中美施贵宝 高瓴系公司接盘；百洋医药一季度净利润增加近46% | 医药早参
每日经济新闻 · 04-29
上海医药清仓中美施贵宝 高瓴系公司接盘；百洋医药一季度净利润增加近46% | 医药早参
上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善
公告速递 · 04-28
上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善
每周股票复盘：上海医药（601607）泼尼松龙片通过一致性评价
证券之星 · 04-26
每周股票复盘：上海医药（601607）泼尼松龙片通过一致性评价
上海医药：附属公司泼尼松龙片通过仿制药一致性评价
财中社 · 04-24
上海医药：附属公司泼尼松龙片通过仿制药一致性评价
大摩：维持上海医药(02607)“增持”评级 目标价降至15.8港元
智通财经网 · 04-24
大摩：维持上海医药(02607)“增持”评级 目标价降至15.8港元
上海医药：公司拥有深厚的中药资源优势
每日经济新闻 · 04-23
上海医药：公司拥有深厚的中药资源优势
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
智通财经 · 04-21
智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨
花旗：降上海医药(02607)目标价至13.5港元 反映毛利受压 重申“买入”评级
智通财经网 · 04-14
花旗：降上海医药(02607)目标价至13.5港元 反映毛利受压 重申“买入”评级
【券商聚焦】高盛维持上海医药(02607)“沽售”评级 微升目标价至10.3元并上调净利润预测
金吾财讯 · 04-13
【券商聚焦】高盛维持上海医药(02607)“沽售”评级 微升目标价至10.3元并上调净利润预测
上海医药：公司挂牌转让上海施贵宝项目正有序推进中
每日经济新闻 · 04-09
上海医药：公司挂牌转让上海施贵宝项目正有序推进中
上海医药(601607.SH)：地高辛片通过仿制药一致性评价
智通财经 · 04-08
上海医药(601607.SH)：地高辛片通过仿制药一致性评价
加载更多
公司概况
公司名称：
上海医药
所属市场：
SEHK
上市日期：
--
主营业务：
上海医药集团股份有限公司是一家主要从事医药分销业务的中国公司。该公司主要经营四个业务分部。工业分部主要从事药品及保健品的研发、生产和销售。分销分部主要从事向医药制造商及配药商提供分销、仓储和其他增值医药供应链解决方案及相关服务。零售分部主要从事经营及加盟零售药店网络。其他分部主要从事其他业务。该公司主要在国内市场经营其业务。
发行价格：
--
{"stockData":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":12.24,"timestamp":1778553292735,"preClose":12.15,"halted":0,"volume":1057700,"delay":0,"changeRate":0.0074074074074073955,"floatShares":919072704,"shares":3708000000,"eps":1.7748901960656918,"marketStatus":"交易中","change":0.09,"latestTime":"05-12 10:35:13","open":12.01,"high":12.29,"low":12.01,"amount":12926856,"amplitude":0.023045,"askPrice":12.24,"askSize":5800,"bidPrice":12.22,"bidSize":9600,"shortable":3,"etf":0,"ttmEps":1.8011666557128096,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1778558400000},"marketStatusCode":2,"adr":0,"listingDate":1305820800000,"exchange":"SEHK","adjPreClose":12.15,"dividendRate":0.036699,"openAndCloseTimeList":[[1778549400000,1778558400000],[1778562000000,1778572800000]],"volumeRatio":1.236558,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":17.19,"timestamp":1778553311000,"preClose":17.15,"halted":0,"volume":4153600,"delay":0,"premium":"-38.22"}},"requestUrl":"/m/hq/s/02607","defaultTab":"news","newsList":[{"id":"2634041495","title":"每周股票复盘：上海医药（601607）利伐沙班片获泰国注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634041495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634041495?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:29","pubTimestamp":1778351351,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，上海医药报收于17.07元，较上周的17.09元下跌0.12%。本周，上海医药5月7日盘中最高价报17.2元。本周关注点公司公告汇总：利伐沙班片获泰国药品注册证书，具备上市销售资格。2025年5月该药品已获美国FDA批准，2025年10月获马来西亚注册证书，2026年2月获新加坡注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0187","BK0028","BK0188","BK0196","02607","BK0020","BK0183","BK0209","BK0099","BK0184","BK0175","BK0012","BK1197","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431583","title":"上海医药（601607）披露持股5%以上股东权益变动触及1%刻度的提示性公告，5月8日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431583","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633431583?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:35","pubTimestamp":1778232954,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，上海医药报收于17.07元，较前一交易日下跌0.35%，最新总市值为633.02亿元。本次权益变动后，控股股东及其一致行动人合计持股比例由38.03%上升至39.00%，增持行为符合相关法律法规，未触发强制要约收购义务，不导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601607","BK0099","BK0188","BK0209","BK0196","BK0175","BK0020","BK0028","BK0097","BK0184","BK0187","02607","BK1197","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633116429","title":"东南亚市场再下一城：上海医药附属公司利伐沙班片在泰国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116429","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633116429?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:36","pubTimestamp":1778142960,"startTime":"0","endTime":"0","summary":"5月7日，上海医药（601607/02607）发布公告，公司下属常州制药厂有限公司生产的利伐沙班片收到泰国食品药品监督管理局颁发的药品注册证书，该药品获得批准上市。利伐沙班片主要用于降低非瓣膜性房颤患者卒中和全身性栓塞的风险、治疗和预防深静脉血栓形成、用于治疗肺栓塞及预防急性病患者静脉血栓栓塞等。截至本公告日，公司针对该药品在东南亚市场上市另投入的研发费用约324.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073730110589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0099","IPOS","BK0175","BK0028","BK0196","BK1197","BK0097","601607","02607","BK0183","BK0187","BK0209","BK0012","BK0184","BK0020","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633974268","title":"大摩：上海医药(02607)首季业绩符预期 予上海医药(601607.SH)A股“与大市同步”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2633974268","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633974268?lang=zh_cn&edition=full","pubTime":"2026-05-06 10:14","pubTimestamp":1778033691,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，上海医药(02607)首季收入为753亿元人民币，同比增长6.4%，纯利为14.18亿元人民币，同比增长6.4%，两者均符合该行预期。大摩提到，上海医药目前正与美国及欧盟跨国的企业，就其研发管线的潜在业务发展机会进行磋商。该行予上海医药(601607.SH)A股“与大市同步”评级，目标价18.8元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","02607","399300","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925374","title":"格隆汇沽空预警榜 | 5月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925374","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633925374?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:15","pubTimestamp":1778004900,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为21.54%，过去两个月大市日均沽空比例为20.42%。其中，PP中新经济-U、X南方中五百、吉利汽车-R沽空比率排名前三位，分别为100.00%、100.00%、100.00%。小米集团-W、盈富基金、阿里巴巴-W的沽空金额排名前三位，分别为30.98亿、28.52亿、15.97亿。IFBH、中国中免、上海医药的偏离值排名前三位，分别为9.28、9.09、6.18。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/06021557004862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2051468812.USD","BK1144","IE00BQXX3C00.GBP","LU0516422440.USD","LU0049112450.USD","LU0084288322.USD","LU2279701549.SGD","SG9999001069.SGD","IE00B0169L03.USD","LU0531970944.HKD","LU2362540622.SGD","LU0348825331.USD","LU0244354667.USD","LU0210526637.USD","83111","BK1517","LU0348805143.USD","LU1880383440.USD","LU0320764599.SGD","LU1211504680.USD","IE00B5MMRT66.SGD","PMRTY","LU0572939691.SGD","LU0791591158.USD","LU1152091168.USD","89988","LU0588546209.SGD","LU1861214812.USD","LU0878005551.USD","LU0348783662.USD","LU0648948544.HKD","LU2360107325.USD","GWLLY","LU1568876251.USD","BK1147","LU0163747925.USD","LU0786609619.USD","LU1810669033.SGD","LU0831103253.SGD","IE0008368411.USD","LU0823397285.USD","LU0878004406.USD","BK1161","LU0072462343.USD","LU0561508036.HKD","LU2023250504.SGD","LU1769817179.HKD","LU1048588211.SGD","09173","LU1242518857.USD","LU1303224171.USD","BABA","LU2778985437.USD","LU0979878070.USD","SG9999015986.USD","LU1880398554.USD","BK1575","SG9999000418.SGD","BK1141","LU1981816686.USD","SGXZ90724238.SGD","LU1655091459.SGD","LU2237443622.USD","SG9999001051.SGD","IE0032431581.USD","LU0708995153.HKD","LU0607220059.USD","LU1734074674.USD","BK1193","LU0254981946.USD","LU1439103000.SGD","BK1119","LU0269904917.USD","LU1720051108.HKD","LU1794554557.SGD","02587","09992","LU1048484197.HKD","LU0128522157.USD","IE0001KFT4U8.USD","HTCD.SI","IE00B8HQ1Z84.USD","SG9999001689.USD","LU0543330566.HKD","LU0048597586.USD","LU0164865239.USD","IE00BPRC5H50.USD","LU2097828714.EUR","LU2293587155.HKD","LU0348788117.USD","LU1235295612.USD","SG9999002950.SGD","MIUmain","LU0831093199.SGD","TCEHY","BK1576","XIACY","LU2348774022.SGD","LU0149721374.USD","BK1501","LU0593848301.USD","LU0029874905.USD","LU0477156797.USD","HXXD.SI","SG9999018857.SGD","LU0868486357.SGD","LU0320764755.SGD","SG9999001846.SGD","LU1244550221.USD","LU1196710864.SGD","LU0039217434.USD","LU0431992006.USD","IE00B543WZ88.USD","LU0203347892.USD","LU1201861165.SGD","SG9999015952.SGD","IE0003851619.USD","LU1105468828.SGD","LU1328615791.USD","LU0106252389.USD","LU1044874839.SGD","LU1813983027.USD","LU1481107354.HKD","LU2462611646.USD","LU1691799644.USD","LU0196878994.USD","601633","LU2247934214.USD","09803","LU0315179316.USD","IE00B8L5B284.USD","LU0823041008.USD","LU1226287529.USD","LU2357125470.USD","LU0871576103.HKD","LU2097828631.EUR","HK0001040168.HKD","03137","LU1675838814.USD","BK1171","LU1282651121.HKD","LU0856984785.SGD","LU1282649067.USD","LU2008162690.USD","LU0261947096.USD","LU0456846285.SGD","09988","688236","LU0128522744.USD","LU1152091754.HKD","LU0797268264.HKD","LU0011963245.USD","LU0327786744.USD","BK1197","LU0049853897.USD","LU0589944569.HKD","LU1808992512.USD","LU2237443895.HKD","LU0348766576.USD","LU0329678170.USD","LU0823426308.USD","LU1196710195.USD","LU1282649810.SGD","LU1733274473.HKD","IE00BZ08YR35.GBP","LU0675040207.SGD","IE00BQXX3F31.USD","BK1610","LU0543330483.HKD","LU1688375341.USD","LU1831875114.USD","LU2357305700.SGD","SG9999001093.SGD","IE00B29SXG58.USD","LU1102505762.USD","BK1540","BK1615","LU0396098781.USD","SG9999006597.SGD","LU0577902611.USD","LU0348827113.USD","SG9999000327.SGD","LU0329678337.USD","BK1608","LU0117841782.USD","BK1224","LU0320764243.SGD","LU1629966141.USD","LU1956131251.USD","IE00B031HW06.USD","LU0502904849.HKD","LU0898667661.SGD","SG9999002463.SGD","SGXZ62798434.SGD","IE00B067MR52.USD","81810","BYDDY","LU2125910849.SGD","LU2449936058.SGD","LU1439102457.SGD","LU0605514214.HKD","HSTECH","TCHmain","BK1506","LU2237443978.SGD","IE00BMPRXN33.USD","SGXZ31699556.SGD","IE0003795394.USD","LU0650527681.SGD","LU0210527791.USD","BK1219","LU0043850808.USD","LU1814569148.SGD","LU2125910500.SGD","LU0359201885.HKD","LU1720050803.USD","LU0345775950.USD","LU0130518102.USD","LU2498475776.HKD","LU1051768304.USD","LU0588545904.SGD","LU2265009873.SGD","IE00B3M56506.USD","LU0823426480.USD","LU0051755006.USD","LU1733274390.USD","HK0000352382.USD","LU2133065610.SGD","BK1522","HK0000914686.HKD","LU0314109678.HKD","LU0211331839.USD","02431","LU0501845795.SGD","IE00B97KM107.HKD","IE0032834883.USD","SG9999015945.SGD","LU0488056044.USD","SG9999004220.SGD","LU0328353924.USD","LU0054237671.USD","LU0828238088.HKD","LU0594300179.USD","LU0181495838.USD","LU0608807433.USD","LU1196710351.USD","LU1861219969.SGD","BK1591","HSI","LU0449515922.USD","LU0683595622.HKD","LU2152927971.USD","IE00BQXX3D17.EUR","LU0886674414.USD","SG9999001226.SGD","LU0633140560.USD","LU2237443382.USD","LU0348767384.USD","ALBmain","SGXZ81514606.USD","LU0572940350.SGD","IE00BZ08YT58.USD","LU0326948709.USD","LU0608807946.USD","LU0175139822.USD","LU0456827905.SGD","SG9999002562.SGD","LU1328277881.USD","LU0541501648.USD","LU0441854154.USD","BK1589","000338","SG9999015978.USD","LU1568876335.HKD","LU1366334651.USD","LU0143863784.USD","LU1880383366.USD","LU0516422366.SGD","LU2249611893.SGD","LU0738912210.USD","LU0417516571.SGD","LU0080751232.USD","LU0127658192.USD","601607","LU0865486749.SGD","LU0463099449.HKD","LU2237443465.HKD","LU1282649141.HKD","LU0762541174.USD","IE00BGV7N243.SGD","LU1868837565.USD","LU1880398471.USD","LU2476274308.USD","BK1618","09159","LU0307460666.USD","LU1770036033.HKD","LU0634319403.HKD","01880","BK1509","LU0203345920.USD","LU0417516738.SGD","LU2294711473.HKD","HK0000320264.USD","LU0516423091.SGD","BK1585","LU0862451753.SGD","BK1249","HK0000107257.USD","SG9999003461.SGD","LU2242644610.SGD","LU0214875030.USD","HK0000914660.USD","IE0008369823.USD","LU0642271901.SGD","LU2362541513.USD","LU1951186391.HKD","LU0197773160.USD","LU2506951792.HKD","IE0031814852.USD","LU0345769128.USD","LU2045819591.USD","LU1785774172.SGD","02410","BK1564","HK0000320223.HKD","LU2148510915.USD","BK1502","LU1993786604.SGD","LU0235996351.USD","LU1868837722.USD","LU0823414478.USD","SG9999017495.SGD","LU0577902454.USD","LU0540923850.HKD","LU0289961442.SGD","BK1516","300759","LU0882747503.HKD","LU0819123356.HKD","01810","SG9999000459.SGD","LU0918141705.HKD","LU0651946864.USD","LU2251237488.HKD","LU0823413660.USD","LU1807302812.USD","LU2039709279.SGD","LU2257852520.SGD","LU0672654166.SGD","IE00BMPRXR70.SGD","LU0588545490.SGD","LU0651947912.USD","SG9999011746.SGD","HK0000352291.HKD","LU0577902371.SGD","IE00B0JY6N72.USD","LU0192582467.USD","LU0890818403.SGD","LU0287142896.SGD","LU1961090484.USD","LU1769817096.USD","002594","LU1960683339.HKD","LU0165289439.USD","BK1584","02607","LU0072913022.USD","LU1064131003.USD","LU1226288253.USD","LU0516423174.USD","LU2488822045.USD","LU0348816934.USD","IE0034224299.USD","LU0048580855.USD","LU0449509016.USD","LU0067412154.USD","LU0823038988.USD","BK1531","HBBD.SI","LU1868838027.USD","BK1526","LU0762542818.HKD","LU0293314216.USD","LU0169518387.USD","LU0229945570.USD","BK1095","LU0823039010.USD","LU2177674079.SGD","LU0106959298.USD","LU0577902538.SGD","LU0047713382.USD","LU0348784397.USD","LU0499858438.USD","LU2294711713.HKD","LU0880133367.SGD","BK1588","LU0823040885.USD","LU1725190679.HKD","03958","LU0918141887.USD","LU1044876610.USD","HYDD.SI","LU1974910355.USD","LU0791590937.USD","LU0384037296.USD","01211","03005","LU0052750758.USD","LU0345776255.USD","SG9999014898.SGD","LU0762540952.USD","LU0588545730.USD","SGXZ99366536.SGD","LU0210533765.USD","LU0823414551.USD","LU0972618739.USD","LU2097829019.USD","LU0140636845.USD","LU0348723411.USD","LU1115378108.SGD","LU0648000940.SGD","IE00B0169N27.USD","LU0164880469.USD","LU1719994722.HKD","SGXZ51526630.SGD","LU1102505929.USD","HK0000306701.USD","03033","LU0611395673.USD","LU1642822792.SGD","LU0505663152.USD","LU0823413587.USD","LU0594300419.USD","LU0315178854.USD","LU1883866441.USD","BK1100","LU1048596156.SGD","LU0211977185.USD","LU0633140727.USD","IE00B031J352.USD","LU0499858602.USD","LU0149534421.HKD","LU1226287792.SGD","LU0577902298.EUR","BK1609","00700","81211","BK1523","LU0251144936.SGD","LU0096374516.USD","LU1718418525.SGD","LU0531971595.HKD","SG9999014906.USD","LU2399975544.HKD","LU0828237940.HKD","BK1237","LU0228659784.USD","IE00BF5LJ272.USD","LU0107464264.USD","LU2362541273.HKD","LU1188198961.HKD","LU0197773673.USD","LU1064130708.USD","LU0456842615.SGD","LU0289739343.SGD","SG9999013353.USD","LU0348814723.USD","LU0143863198.USD","HK0001040143.USD","LU1008478684.HKD","SG9999002828.SGD","LU0348735423.USD","83189","BK1582","LU2543165471.USD","02338","LU2237443549.SGD","LU1323998911.USD","LU0630378429.USD","SG9999006514.SGD","SG9999014674.SGD","LU0173614495.USD","IE00B031HY20.USD","SG9999018865.SGD","LU0370786039.SGD","LU2251237306.USD","LU0862451837.USD","LU0130103400.USD","LU0516422952.EUR","LU0708995583.HKD","LU2087589342.USD","LU0873338254.USD","BK1607","LU2097828557.USD","LU2476274720.SGD","LU0737861699.HKD","LU0823397103.USD","80175","LU0164872284.USD","BK1586","BK1583","LU0061477393.USD","SG9999001903.USD","BK1142","LU0261950983.USD","LU0469268626.HKD","LU1515016050.SGD","LU1548497426.USD","LU0264606111.USD","LU0231483743.USD","LU0700851271.USD","LU1051769294.HKD","LU0054450605.USD","LU0326950275.SGD","LU0048388663.USD","LU0345769631.USD","BK1521","LU1917777945.USD","IE0009570106.USD","601888","LU0289960550.SGD","BK1539","LU0359201612.USD","82333","LU1224444064.USD","HK0000151867.HKD","LU0348783233.USD","01951","LU3063872942.SGD","LU0188438112.USD","LU2097828474.EUR","LU1224709979.USD","LU1226288097.SGD","LU1504937902.USD","LU1242518931.SGD","IE00BZ08YS42.EUR","HK0000165453.HKD","LU0509642566.USD","LU0640798160.USD","LU1720051017.SGD","IE0003895053.USD","LU0228367735.SGD","03759","SHPMY","LU0414403682.SGD","IE00BD6J9T35.USD","LU0630378692.HKD","LU0828237510.HKD","LU2153592121.USD","LU0819121731.USD","LU1046422090.SGD","02800","LU2097828805.USD","SG9999014880.SGD","LU0784639295.USD","LU1023057109.AUD","LU1366334578.USD","LU1282651048.USD","LU0985320562.USD","LU2226246903.HKD","06603","BK1594","SGXZ86797644.SGD","01858","LU0359202008.SGD","LU0070217475.USD","LU1282648689.USD","LU0132412106.USD","LU1226288170.HKD","LU0106259558.USD","HK0000286598.CNH","LU0117844026.USD","LU1044875133.USD","LU0572944931.SGD","LU1316542783.SGD","SG9999007991.SGD","LU0737861772.HKD","LU0821914370.USD","LU2106854487.HKD","LU0029875118.USD","GB00BDT5M118.USD","LU2317271919.USD","LU0417516902.SGD","LU0259732245.USD","HK0000306685.HKD","LU1226287875.USD","LU1244550494.USD","LU0455707207.USD","LU1770034418.SGD","SG9999014914.USD","LU1804176565.USD","LU0511384066.AUD","LU1251922891.USD","IE0008368742.USD","IE0008368304.USD","LU0541502299.USD","BK1597","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2632647733","title":"每周股票复盘：上海医药（601607）一季度营收752.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632647733?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:33","pubTimestamp":1777667591,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，上海医药报收于17.09元，较上周的16.88元上涨1.24%。本周，上海医药4月30日盘中最高价报17.12元。本周关注点来自业绩披露要点：上海医药2026年一季报显示，一季度主营收入752.62亿元，同比上升6.36%。上海医药2026年第一季度实现营业收入752.62亿元，同比增长6.36%；归属于上市公司股东的净利润14.18亿元，同比增长6.35%。上海医药集团股份有限公司第八届董事会第三十次会议于2026年4月29日召开，会议应到董事10名，实到10名，符合法定人数要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632677836","title":"上海医药（601607）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632677836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632677836?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:20","pubTimestamp":1777587634,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期上海医药发布2026年一季报。截至本报告期末，公司营业总收入752.62亿元，同比上升6.36%，归母净利润14.18亿元，同比上升6.35%。本报告期上海医药盈利能力上升，毛利率同比增幅4.86%，净利率同比增幅6.05%。本次财报公布的各项数据指标表现尚佳。持有上海医药最多的基金为工银创新动力股票，目前规模为16.74亿元，最新净值1.273，较上一交易日下跌0.62%，近一年上涨16.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100004998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111906483","title":"上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111906483","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111906483?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:11","pubTimestamp":1777453866,"startTime":"0","endTime":"0","summary":"2026年第一季度，上海医药实现营业收入752.62亿元，同比增长6.36%。经调整净利润12.38亿元，同比下降2.02%。同期内，公司经营活动产生的现金流量净额为-10.10亿元，较上年同期的-22.04亿元显著改善，同比增长54.19%。报告期内，公司综合营业成本为728.26亿元，高于上年同期的686.67亿元。销售费用为32.75亿元，管理费用13.16亿元，财务费用3.57亿元。医药工业板块实现销售收入68.06亿元，同比增长15.64%；医药商业板块实现销售收入684.56亿元，同比增长5.52%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631598761","title":"上海医药(02607)一季度归母净利润14.18亿元 同比增长6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631598761","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631598761?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:04","pubTimestamp":1777453483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(02607)发布2026年第一季度报告，营业收入752.62亿元(人民币，下同)，同比增长6.36%。归属于上市公司股东的净利润14.18亿元，同比增长6.35%。基本每股收益0.3823元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537129","title":"上海医药清仓中美施贵宝 高瓴系公司接盘；百洋医药一季度净利润增加近46% | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537129","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537129?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:04","pubTimestamp":1777417480,"startTime":"0","endTime":"0","summary":"丨2026年4月29日星期三丨NO.1泰格医药一季度净利润同比减少70.36%4月28日，泰格医药发布2026年一季报，公司实现营业收入18.01亿元，同比增加15.17%；实现归属于上市公司股东的净利润4904.31万元，同比减少70.36%；实现归属于上市公司股东的扣除非经常性损益的净利润1.20亿元，同比增加17.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604293723254882.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604293723254882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601607","BMY","301015","09939","159938","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167025210","title":"上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1167025210","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167025210?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:46","pubTimestamp":1777365987,"startTime":"0","endTime":"0","summary":"上海医药披露2025年年度报告，显示公司整体收入稳步增长，核心业务持续扩张，盈利能力与现金流同步改善。2025年公司实现营业收入人民币2,835.80亿元，较2024年的2,752.51亿元增长2.97%。营业成本为人民币2,531.63亿元，增幅3.69%，与收入增长基本保持一致。截至2025年12月31日，集团总资产为人民币2,331.49亿元，较上年增长5.40%；流动资产合计为人民币1,804.64亿元。整体来看，上海医药在2025年继续维持业绩增势，营业收入与净利润均实现稳中有升，经营活动现金流也进一步增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630047801","title":"每周股票复盘：上海医药（601607）泼尼松龙片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2630047801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630047801?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:13","pubTimestamp":1777144390,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，上海医药报收于16.88元，较上周的16.99元下跌0.65%。本周关注点公司公告汇总：泼尼松龙片通过仿制药一致性评价，有利于提升市场竞争力公司公告汇总：泼尼松龙片一致性评价研发投入约800万元公司公告汇总：2025年大陆医院采购金额为224.7万元公司公告汇总上海医药集团股份有限公司下属天津信谊津津药业有限公司收到国家药监局颁发的泼尼松龙片《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0184","BK0020","BK0099","BK1197","601607","BK0097","BK0175","BK0012","BK0187","BK0196","BK0188","BK0028","BK0183","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629176718","title":"上海医药：附属公司泼尼松龙片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2629176718","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629176718?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:02","pubTimestamp":1777024920,"startTime":"0","endTime":"0","summary":"4月24日，上海医药（601607/02607）发布公告，公司下属天津信谊津津药业有限公司的泼尼松龙片通过仿制药一致性评价。泼尼松龙片主要用于过敏性与自身免疫性炎症性疾病，胶原性疾病。截至本公告日，公司针对该药品的一致性评价已投入研发费用约800万元。2025年，上海医药实现收入2835.80亿元，归母净利润57.25亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243718154291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0187","BK0209","BK1197","BK0184","BK0028","BK0020","BK0175","BK0188","BK0099","BK0183","BK0012","601607","BK0196","02607","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629811598","title":"大摩：维持上海医药(02607)“增持”评级 目标价降至15.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629811598","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629811598?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:40","pubTimestamp":1777020012,"startTime":"0","endTime":"0","summary":"大摩预计公司2025至28年整体盈利年复合增长率达9%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260424/20260424163026_37156.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260424/20260424163026_37156.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["EWH","02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629351528","title":"上海医药：公司拥有深厚的中药资源优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2629351528","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629351528?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:09","pubTimestamp":1776942574,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：董秘好,八字补肾胶囊的量价齐升,效益明显.贵司的青春宝抗衰老片作为老牌抗衰老产品，拥有近50年的市场历史和大量研究文献支持，在“气阴两虚”这一细分人群中拥有稳固的市场基础和极高的用户忠诚度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604233716306035.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233716306035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","601607","BK0184","BK0196","BK0099","02607","BK0097","BK0183","BK0188","BK0012","399319","BK0020","BK0175","BK0028","BK0209","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772986","title":"智通港股早知道 | 宁德时代(03750)股东询价转让A股定价为410.34元/股 氮肥价格可能进一步上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772986","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629772986?lang=zh_cn&edition=full","pubTime":"2026-04-21 07:28","pubTimestamp":1776727718,"startTime":"0","endTime":"0","summary":"根据2026年4月20日询价申购情况，初步确定的本次询价转让价格为410.34元/股。本次询价转让不通过集中竞价交易方式或大宗交易方式进行，不属于通过二级市场减持。受让方通过询价转让受让的股份，在受让后6个月内不得转让。截至收盘，暗盘交易显示报价333港元，较招股价209.88港元上涨58.66%，每手100股，不计手续费，每手赚12312港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bd99c7d8869305150ea2122170bfd90e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0449515922.USD","LU1048588211.SGD","LU0259732245.USD","LU0029875118.USD","LU0244354667.USD","LU1770034418.SGD","IE00BZ08YR35.GBP","LU0359201885.HKD","LU0594300179.USD","LU0979878070.USD","LU1146622755.USD","LU1868838027.USD","02607","LU2092937221.SGD","LU0164872284.USD","BK4519","LU2152927971.USD","LU2238339852.HKD","LU0320764755.SGD","IE0003851619.USD","LU1064130708.USD","LU2045819591.USD","LU1720050803.USD","LU0048388663.USD","LU2424517915.HKD","LU0140636845.USD","LU2294711713.HKD","LU1781817850.SGD","LU0251143458.SGD","IE00B8L5B284.USD","IE00B5MMRT66.SGD","BK0224","LU0469268626.HKD","SHPMY","LU0531970944.HKD","LU0724618433.USD","LU0302445910.USD","LU0043850808.USD","LU0067412154.USD","LU0611395673.USD","LU0505663152.USD","09696","SNFRY","LU0128522157.USD","LU0106959298.USD","LU0516423091.SGD","LU0051755006.USD","LU0823426480.USD","LU0048580855.USD","LU0106259558.USD","LU1951186391.HKD","LU1997245177.USD","LU1820825898.SGD","02476","HK0000181138.USD","LU1188198961.HKD","BK4585","LU0348805143.USD","300750","LU2394011477.USD","LU0456827905.SGD","LU1808992512.USD","LU1831875114.USD","LU0210526637.USD","LU2506952410.USD","LU2097828474.EUR","603093","LU2477742899.HKD","LU2275660780.HKD","BK1154","301200","BK4526","LU0359202008.SGD","SG9999014674.SGD","LU2041044095.USD","BK4141","LU1226287529.USD","LU0124384867.USD","BK1521","SG9999002828.SGD","LU0192582467.USD","LU0449509016.USD","BK1129","SG9999000327.SGD","002466","IE00BZ08YS42.EUR","LU0593848301.USD","LU1102505929.USD","LU1303224171.USD","LU1152091168.USD","02691","LU0828237940.HKD","LU0214875030.USD","BK1610","LU2097828714.EUR","LU0235996351.USD","LU0572944931.SGD","LU0326950275.SGD","LU2399975544.HKD","LU0326948709.USD","LU0143863198.USD","LU2506952337.HKD","IE0003795394.USD","PLUG","LU1102505762.USD","LU0269904917.USD","LU0107464264.USD","LU1008478684.HKD","IE00BPRC5H50.USD","LU0047713382.USD","00719","IE00B031HY20.USD","BK1191","EVS.SI","LU1515016050.SGD","HK0000165453.HKD","LU0228659784.USD","LU0314109678.HKD","LU0254981946.USD","LU0821914370.USD","LU1226287875.USD","LU1251922891.USD","BK1147","LU1580142542.USD","LU1960683339.HKD","BK1116","LU2476274308.USD","LU1023057109.AUD","IE0008368742.USD","00451","IE0008369823.USD","LU1868837565.USD","LU3063872942.SGD","TSLA","LU0072462343.USD","LU0328353924.USD","LU1051769294.HKD","LU2289578879.USD","BK1515","LU0516422440.USD","LU2039709279.SGD","03983","LU1993786604.SGD","06608","LU1051768304.USD","HK0000181112.HKD","LU0455707207.USD","LU0828237510.HKD","LU1719994722.HKD","SG9999002463.SGD","LU2328871848.SGD","LU0011963245.USD","01866","LU1152091754.HKD","LU0039217434.USD","LU0531971595.HKD","LU2148510915.USD","SGXZ81163826.USD","SG9999004220.SGD","IE00B3M56506.USD","LU0543330483.HKD","LU0315179316.USD","LU0312595415.SGD","IE00B8HQ1Z84.USD","SG9999001846.SGD","LU0823437842.USD","LU1255011170.USD","CBLUY","LU2298064838.USD","BK1554","03750","IE00BZ199S13.USD","LU1064131003.USD","SGXZ49509284.SGD","LU0607220059.USD","LU2580892862.HKD","LU0509642566.USD","LU0605514214.HKD","LU1997245094.SGD","SG9999003461.SGD","LU0516423174.USD","LU1979443071.USD","LU2506952253.HKD","LU2778985437.USD","LU1997244956.HKD","LU0359201612.USD","LU1969619763.USD","LU0106252389.USD","LU1861214812.USD","LU2294711473.HKD","LU2357125470.USD","LU1721428347.USD","LU2476274720.SGD","01093","COIN","LU2153591404.USD","LU1934453819.USD","LU0823426308.USD","LU0651947912.USD","LU0143863784.USD","LU0880133367.SGD","LU1048596156.SGD","LU0049853897.USD","LU0871576103.HKD","LU2125910500.SGD","LU1880383440.USD","LU0502904849.HKD","LU2348774022.SGD","LU1794554557.SGD","LU2249611893.SGD","LU2449936058.SGD","META","SG9999000459.SGD","LU1039395188.USD","LU1880383366.USD","LU0370786039.SGD","LU0405327148.USD","INTC","LU0405327494.USD","LU2097828805.USD","IE0032431581.USD","LU1807302812.USD","LU0501845795.SGD","LU0181495838.USD","LU0823414478.USD","300476","LU1226287792.SGD","LU1655091616.SGD","LU2360108059.USD","00941","LU1961090484.USD","BK1594","IE00B543WZ88.USD","LU0672654166.SGD","601607","LU0048575426.USD","03393","LU0188438112.USD","LU0327786744.USD","LU0516422366.SGD","LU0516422952.EUR","600941","LU0650527681.SGD","LU0823414551.USD","LU0054450605.USD","LU2097828557.USD","LU2298321311.HKD","SG9999001689.USD","LU1226288253.USD","LU0463099449.HKD","LU1242518857.USD","LU1813983027.USD","LU0165289439.USD","03200","LU2506951792.HKD","LU2125910849.SGD","LU0132412106.USD","LU1769817179.HKD","LU2360107325.USD","IE00BZ08YT58.USD","SG9999001903.USD","BK4588","IE00B29SXG58.USD","04335","LU2097828631.EUR","LU1939255532.USD","LU2242644610.SGD","LU0594300419.USD","LU0828238088.HKD","LU2580892789.USD","LU2495084118.USD","LU0164865239.USD","LU2348773727.SGD","LU1978683503.SGD","02575","LU0231483743.USD","IE00BD6J9T35.USD","LU0149534421.HKD","LU0072913022.USD","000756","LU1242518931.SGD","00297","LU2298322129.HKD","LU0261950470.USD","LU1769817096.USD","LU1328277881.USD","LU0651946864.USD","LU1861219969.SGD","LU2153592121.USD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627415721","title":"花旗：降上海医药(02607)目标价至13.5港元 反映毛利受压 重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627415721","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627415721?lang=zh_cn&edition=full","pubTime":"2026-04-14 15:33","pubTimestamp":1776152029,"startTime":"0","endTime":"0","summary":"该行认为，管理层执行风险、整合进度慢于预期，及处方药网上销售放宽政策出台慢于预期等，均为下行风险。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260414/20260414153119_10699.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260414/20260414153119_10699.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["EWH","601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627816804","title":"【券商聚焦】高盛维持上海医药(02607)“沽售”评级 微升目标价至10.3元并上调净利润预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2627816804","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627816804?lang=zh_cn&edition=full","pubTime":"2026-04-13 13:32","pubTimestamp":1776058351,"startTime":"0","endTime":"0","summary":"金吾财讯 | 高盛发表研报指，上海医药(02607)第四季收入685亿元，按年增长4.4%，高于该行预期的659亿元，主要由制造业务板块的稳健表现带动；同期净利润为5.78亿元，按年增长16%，低于该行预期的12亿元，主要由于创新药商业化带动销售开支大幅增加，以及期内确认的投资损失及资产减值。该行将其2026至2027年净利润预测分别上调5.8%及1.7%，以反映销售开支增加及上海和黄药业的合并，引入2028年每股盈利预测1.06元；目标价由10.03港元上调至10.3港元，维持“沽售”评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978745","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902114","title":"上海医药：公司挂牌转让上海施贵宝项目正有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902114","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626902114?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:15","pubTimestamp":1775722547,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：董秘您好，请问公司挂牌转让所持上海施贵宝股份进展如何？公司今年对创新药研发计划投入由增加吗？上海医药（601607.SH）4月9日在投资者互动平台表示，公司挂牌转让上海施贵宝项目正有序推进中，相关交易进展公司会按照监管要求及时履行信息披露义务，请您继续关注公司公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604093699584342.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604093699584342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601607","BK0188","LU0882574055.USD","LU2242652126.USD","BMY","LU0237698245.USD","LU2360032135.SGD","BK0187","02607","BK0183","LU0061475181.USD","LU1868837136.USD","BK0028","LU1868837300.USD","LU0096364046.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0985481810.HKD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU1670711123.USD","BK4534","BK0184","LU0321505868.SGD","BK4585","BK0012","LU0267386448.USD","BK0020","LU1261432733.SGD","LU1670711040.USD","LU2242646821.SGD","LU1291159041.SGD","LU1074936037.SGD","LU2133065610.SGD","LU2125154935.USD","LU1093756325.SGD","IE00B2B36J28.USD","BK4559","LU0306807586.USD","BK0209","BK1197","BK4588","BK4532","LU0321505439.SGD","LU0225771236.USD","LU1883839398.USD","LU1032466523.USD","LU1585245621.USD","LU1868836914.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625916959","title":"上海医药(601607.SH)：地高辛片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2625916959","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625916959?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:04","pubTimestamp":1775635449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药 发布公告，近日，公司下属上海上药信谊药厂有限公司的地高辛片收到国家药品监督管理局颁发的《药品补充申请批准通知书》，该药品通过仿制药一致性评价。地高辛片适用于1、治疗成人轻度至中度心力衰竭。地高辛可增加左心室射血分数并改善心力衰竭症状，表现为提高运动能力和减少心力衰竭相关住院和急诊治疗，而对死亡率无影响。在可能的情况下，地高辛应与利尿剂和血管紧张素转换酶抑制剂联合使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","BK0175","BK0012","BK0028","BK0097","BK0184","BK0188","BK0020","02607","BK0183","BK0196","BK1197","BK0209","BK0099","BK0187"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shaphar.com.cn","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.0133},{"period":"3month","weight":0.0279},{"period":"6month","weight":0.0158},{"period":"1year","weight":0.1818},{"period":"ytd","weight":0.0677}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.1548},{"period":"ytd","weight":0.0303}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海医药集团股份有限公司是一家主要从事医药分销业务的中国公司。该公司主要经营四个业务分部。工业分部主要从事药品及保健品的研发、生产和销售。分销分部主要从事向医药制造商及配药商提供分销、仓储和其他增值医药供应链解决方案及相关服务。零售分部主要从事经营及加盟零售药店网络。其他分部主要从事其他业务。该公司主要在国内市场经营其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.005835},{"month":2,"riseRate":0.533333,"avgChangeRate":0.014987},{"month":3,"riseRate":0.533333,"avgChangeRate":0.009535},{"month":4,"riseRate":0.533333,"avgChangeRate":0.000642},{"month":5,"riseRate":0.533333,"avgChangeRate":0.00082},{"month":6,"riseRate":0.466667,"avgChangeRate":-0.011244},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017077},{"month":8,"riseRate":0.4,"avgChangeRate":0.011563},{"month":9,"riseRate":0.333333,"avgChangeRate":0.013086},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.021401},{"month":11,"riseRate":0.466667,"avgChangeRate":0.029705},{"month":12,"riseRate":0.533333,"avgChangeRate":-0.012575}],"exchange":"SEHK","name":"上海医药","nameEN":"SH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,02607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}